Trials / Completed
CompletedNCT03182946
Correcting Platelet Dysfunction After Traumatic Brain Injury
Correction of Platelet Dysfunction Following Traumatic Brain Injury in Geriatric Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 147 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the impact of platelet transfusion on geriatric patients with platelet dysfunction from Traumatic Brain Injury. The authors hypothesize that patients will recover better if their platelet dysfunction is corrected with platelet transfusion.
Detailed description
The geriatric population is subject to traumatic brain injury, often occurring as a result of falls. This patient population is also often receiving anticoagulants and platelet inhibitors increasing their risk of post-injury hemorrhage. Following Traumatic Brain Injury, even without platelet inhibitor medications, platelets become dysfunctional and are no longer able to assist with clot formation. Therefore risk of hemorrhage is increased, both in the brain, and other hemorrhagic sites. Clinical practice at Carolinas Medical Center is to transfuse platelets in patients with platelet dysfunction following brain injury. The current study is investigating the impact of transfusion on correction of platelet dysfunction and patient outcome. Furthermore, stored platelet dysfunction can be corrected by supplementation with cytochrome c, which supports mitochondrial function. Therefore, the ability of cytochrome c to correct dysfunction in ex vivo platelets from patients with Traumatic Brain Injury will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Platelet mapping Thromboelastography | These diagnostic tests will be acquired in patients with brain injury, to determine prediction of clinical, functional and psychological outcome. |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2021-07-01
- Completion
- 2021-07-01
- First posted
- 2017-06-09
- Last updated
- 2022-04-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03182946. Inclusion in this directory is not an endorsement.